Latest Posts

Company Profile

Coronis NeuroSciences  is a specialty pharma company focused on the development of Innovative therapies in the fields of Neurocognitive and Neurodegenerative disorders. The company owns a pipeline of several clinical and pre-clinical stage molecules and strives to build  value through the clinical development of cutting-edge propriety formulated drugs.

 

Read More

Pipeline

CP101 Ethosuximide Developed for the treatment of drug-resistant Glaucoma – An Ocular Neurodegenerative disease


Read More
CP102 SKIP A Novel Short NAP Analogue Based on the NAP Active Site
Read More
CP201 Davunetide A trans-nasally delivered peptide developed for the treatment of Cognitive Impairment Associated with Schizophrenia
Read More